Physician profile
Christopher Peyton Yarbrough
NPI 1396153524
$4,549.72
in general payments reported to CMS, 2019-2025
18 companies · $707 in 2025
The $707 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $462 · 2021: $552 · 2022: $991 · 2023: $562 · 2024: $427 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,696.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $918.20 | 2019-2025 | Tryptyr, Simbrinza, Rhopressa |
| Sun Pharmaceutical Industries INC. | $764.40 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $607.86 | 2019-2021 | |
| Allergan, INC. | $515.74 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $239.08 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Coopervision INC. | $221.67 | 2019-2024 | Misight Contact Lens, Myday Contact Lens |
| Abbvie INC. | $208.92 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Eyevance Pharmaceuticals LLC | $161.33 | 2022 | |
| Biotissue Holdings INC. | $122.79 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $119.59 | 2022-2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $114.68 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $110.81 | 2019 | |
| Glaukos Corporation | $102.72 | 2023 | |
| Dompe US, INC. | $101.40 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $101.28 | 2022-2024 | Tyrvaya, Ryzumvi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $67.53 | 2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $55.68 | 2022 | |
| Alcon Research LLC | $16.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Yarbrough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.